Health Canada approved EDAP TMS’s (Nasdaq: EDAP) Focal One HIFU device
to treat prostate cancer sending the stock price up 75 cents to $3.07.
EDAP’s Focal One HIFU device approved
January 09, 2015 at 05:36 AM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.